»ó´Ü¿©¹é
±â»ç (Àüü 803°Ç)
[Cover Story] 1Â÷Áø·áÀÇ°¡ ¸¸¼ºÁúȯ¿¡ ¹¯´Ù ÀÌ»óµ· ±âÀÚ 2023-10-05 11:24
[Sub Story] ½ºÅ¸Æ¾ 1Â÷Ä¡·á¿Í LDL-C¡¤ASCVD Á¶Àý¡¤¿¹¹æÀÇ ¹ßÀÚÃë ÀÌ»óµ· ±âÀÚ 2023-10-05 11:03
[Sub Story] ¸ñÇ¥´Þ¼º À§ÇØ Áõ·®ÇÒ °ÍÀΰ¡? º´¿ëÇÒ °ÍÀΰ¡? ÀÌ»óµ· ±âÀÚ 2023-10-05 10:34
[Sub Story] Ç×°íÇ÷¾ÐÁ¦ º´¿ëó¹æ ¿Ö¡¤¾ðÁ¦¡¤¾î¶»°Ô? ÀÌ»óµ· ±âÀÚ 2023-10-04 16:58
[Interview] ±¹³» ÃÖÃÊÀÇ 4Á¦ º¹ÇÕÁ¦ ¾Æ¸ðÀßź¿¢½ºÅ¥
±¹³» ȯÀÚ´ë»ó 3»ó¿¬±¸ °á°ú ±¹Á¦ÇмúÁö °ÔÀç
ÀÌ»óµ· ±âÀÚ 2023-10-04 16:51
¶óÀÎ
[Sub Story] °íÇ÷¾Ð¡¤ÀÌ»óÁöÁúÇ÷Áõ µ¿¹ÝÀÌȯ ¾à¹°°³¼ö ¾îµð±îÁö °¡´ÉÇÒ±î? ÀÌ»óµ· ±âÀÚ 2023-10-04 16:46
[Deep in Guideline] [´ëÇÑ°íÇ÷¾ÐÇÐȸ 2022³â °íÇ÷¾Ð Áø·áÁöħ]
¡°È°µ¿Ç÷¾ÐÃøÁ¤ 1Â÷±â°ü¼­ ¿ëÀÌÇÏÁö ¾ÊÀ» ¼öµµ¡±
ÀÌ»óµ· ±âÀÚ 2023-10-04 16:24
[Sub Story] 1Â÷Ä¡·áÁ¦ ¼±ÅñâÁØ ¹«¾ùÀÌ ´Þ¶óÁ³³ª? ÀÌ»óµ· ±âÀÚ 2023-10-04 16:15
[Conference Report] 1ÀÏ 2ȸ ¾Æ³ª±Û¸³Æ¾ ¾ÈÁ¤·Áö¼Ó Ç÷´çÁ¶Àý¿¡¼­ Ç÷´çº¯µ¿¼º °³¼±±îÁö ÀÌ»óµ· ±âÀÚ 2023-10-04 15:58
[Conference Report] °Ç°­°ËÁø ÄÝ·¹½ºÅ×·Ñ °Ë»çÁֱ⠡°4³â¡æ2³âÀ¸·Î ´ÜÃàÇؾߡ± ÀÌ»óµ· ±âÀÚ 2023-10-04 15:48
¶óÀÎ
[Sub Story] Ä¡¸Å, Á¶Àý °¡´ÉÇÑ Áúº´À¸·Î ±¹¸éÀüȯ ÀÌ»óµ· ±âÀÚ 2023-09-04 16:10
[Conference Report] DAPT¿¡¼­ ¾Æ½ºÇǸ°ÀÇ Á¸Àç°¨Àº? ÀÌ»óµ· ±âÀÚ 2023-09-04 15:09
[Drug Review] º£´ÏµðÇÉ, L¡¤N¡¤T-type Ä®½·Ã¤³Î Â÷´Ü À¯ÀÏ CCB ÀÌ»óµ· ±âÀÚ 2023-09-04 14:54
[Sub Story] ¡°PPI À§ÇèÀº À̷мöÁØ¡¦ÇýÅà ÈξÀ Ä¿¡± ÀÌ»óµ· ±âÀÚ 2023-08-07 16:20
[Interview] ¡°GERD¿¡ P-CAB ÃÊÄ¡·á °¡´É¼º¡è¡± ÀÌ»óµ· ±âÀÚ 2023-08-07 16:15
¶óÀÎ
[Sub Story] P-CAB, GERD ÃʱâÄ¡·á¿¡ µîÀç ÀÌ»óµ· ±âÀÚ 2023-08-07 15:56
[Sub Story] ¡°¹Ì¶õ¼º À§¿°¿¡ PPIs °í·ÁÇÒ ¼ö À־ ÀÌ»óµ· ±âÀÚ 2023-08-07 15:36
[Late Breaking Studies] ½Ç·Î½ºÅ¸Á¹, ´ç´¢º´¡¤PAD µ¿¹Ý½Ã ÇÏÁöÀý´Ü À§Çè°¨¼Ò ½Ã»ç ÀÌ»óµ· ±âÀÚ 2023-07-27 11:51
[Cover Story] Çѱ¹ÀÎ ³úÁ¹Áß, ¼­¾ç°ú À¯º´Æ¯¼º ´Ù¸£´Ù ÀÌ»óµ· ±âÀÚ 2023-07-05 16:49
[Sub Story] ¡°ICAS¡¤¼ÒÇ÷°üÁúȯ¡¤ÃâÇ÷¿¡ ÁÖ¸ñÇؾߡ± ÀÌ»óµ· ±âÀÚ 2023-07-05 16:43
Back to Top